BeLiver
My visitor profile
BeLiver
Description of your activity
- BeLiver is currently developing a technology that combines proteomic analysis and IA to reveal unique protein signatures, enabling the predict the most effective treatment available for cancer patients. Two pilot trials on liver treatments have already been carried out. BeLiver's technology can be used on all cancers requiring a solid biopsy and can highlight potential therapeutic targets.
More information
Emerging company
Madeleine MOSCATELLI
Co founder
Date of your company creation:
- Less than 1 year
Main sector
- Academic research, Biotechnology - Therapeutics and Diagnostics
Address
- Country : FRANCE
- City : Bordeaux
- Zip Code : 33000
Participation objectives
Partnering objectives
- Financing / investment opportunities, Network development